News
FDA approves new tubeless insulin pump
It offers users a choice of bolusing directly from the pump or from a handheld remote-control device.
News
Type 1 diabetes management improves as technology advances
Automated insulin delivery systems have reduced A1c levels, but many still are not achieving numbers under 7%.
News
FDA okays first-ever new drug for rare bone disorder
The drug reduced annualized heterotopic ossification volume by 54%.
News
Cause of common gastrointestinal symptoms in diabetes?
“People with diabetes who present with gastrointestinal symptoms – such as steatorrhea or changes in stool, bloating, and/or abdominal pain –...
News
A1c not linked to postop complications in kids with diabetes
There is no guidance on the level of elevated A1c that should prompt consideration of delaying surgery.
News
Just 1 in 10 with overweight/obesity lose 5% of body weight
“These findings could, in part, be explained by barriers in availability of and access to obesity management options.”
News
Skin reactions common at insulin pump infusion sites
The inflammatory response “may result in tissue changes responsible for the infusion-site failures seen frequently in clinical practice,” say the...
News
Kombucha benefits type 2 diabetes, study suggests
“Kombucha is a growing part of the beverage market in the United States and the world.”
News
New approaches for diabetic keratopathy in the eye?
“Our goal is to develop topical, sustained-release drugs for corneal wound healing.”
News
New guidelines on diabetes-related laboratory testing
“We do a lot of testing in screening, diagnosis, and monitoring of diabetes and its complications, yet for many clinicians we think that any...
Opinion
Debate: Initial combination therapy for type 2 diabetes?
Ralph A. DeFronzo, MD, argued for combination therapy at the time of diagnosis, and David M. Nathan, MD, countered that sequential therapy is a...
News
FDA clears the Tandem Mobi insulin pump
The device is approved for people with diabetes aged 6 years and up.
News
Aging and type 1 diabetes: ‘Complete picture’ 40 years on
“The EDIC study is now shifting its focus during the next 5 years to understand the clinical course of type 1 diabetes in the setting of advancing...
News
COORDINATE-Diabetes: A ‘wake-up call’ for many specialties
“I look at COORDINATE as a wake-up call to the need for multispecialty approaches to people with type 2 diabetes and cardiovascular disease.”
News
Thirty-three percent of type 1 diabetes patients insulin free with stem cells
Engraftment of Vertex Pharmaceutical’s VX-880 stem cell–derived islets has now been achieved in six patients, two of whom are insulin-independent...